Search

This initiative aims to have a positive long term impact on the environment, economy and society by helping achieve 10 of the Sustainable Development Goals (SDG).

January 10th, in an event with numerous institutional representatives, headed by the Lehendakari Iñigo Urkullu, together with representatives from the business, financial, scientific-technological and

The Investor Day, organized by AseBio and positioned as the benchmark meeting between investors and Spanish biotech companies, will take place on May 15th.

Innovation has enabled breakthroughs such as recent drugs for Alzheimer's disease, the use of devices that stimulate brain function for the treatment of certain pathologies or Virtual Reality for post

Funding will Support Development of AI Clinician, Using Spatial Computing.

AseBio has been a key player in the journey taken over these 25 years by biotechnology in Spain, positioning itself as a strategic agent in the face of challenges and future prospects.

The objective of this study was to analyze the impact of glaucoma in ambulatory centers and hospitals in Spain over the past decade and to measure the associated direct medical costs and incidence.

Due to Spain's scientific and technological potential, both in the public and private sectors, our country has the responsibility to give a new boost to the biotechnological sector and thus respond to

Results across all efficacy endpoints consistently favored vafidemstat over placebo. Global Statistical Test (GST p-values) confirms consistent trend across efficacy endpoints.

To drive research efforts, it is key to choose world-class controls, and to understand them not as mere tools, but as indispensable assets that guarantee the highest quality standards, saving time and

He highlights his participation in the 7º Sachs Annual Neuroscience Innovation Forum, 13º Annual LifeSci Advisors Corporate Access Event, Biotech Showcase-2024, 42º Annual J.P. Morgan Healthcare

In 2022, the Inflation Reduction Art (IRA) became US law with the aim to reduce drug costs.

The SAB will provide strategic guidance on the company's research and development efforts and strategy, particularly focused on the FiCAT gene writing platform that improves the development of gene